Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spermatogenesis-associated protein 31A6 (SPATA31A6) is a human protein-coding gene predominantly expressed in the testes, where it may play a role in spermatogenesis, specifically in cell differentiation and actin binding[1][4][5]. It localizes to the acrosomal vesicle and is hypothesized to contribute to processes essential for sperm development, but its exact molecular function in humans remains incompletely characterized[1][4]. Although functional studies are lacking for SPATA31A6 specifically, other closely related SPATA proteins are critical for sperm head development and male fertility in animal models, suggesting potential relevance in human reproductive biology[2]. No evidence supports its classification as a conventional therapeutic target (receptor, enzyme, transporter, etc.), and there is no documentation of drugs, biomarkers, or safety issues associated with this protein[1][4][5].
None established
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spermatogenesis-associated protein 31A6 (SPATA31A6).